Irritable bowel syndrome (IBS) patients attending secondary and tertiary care gastroenterology clinics not infrequently give a history of surgical interventions as well as multiple investigations which sometimes do not appear to be entirely necessary. The commonest operations are hysterectomy, cholecystectomy, appendicectomy, pelvic floor procedures and even back surgery. The outcome from these operations is not always good and on occasions patients claim that their IBS symptoms, especially abdominal pain, have been worse since the surgery. In 1986, we reported that, compared to healthy controls, IBS patients experience a range of 'non-colonic' symptoms such as gynaecological complaints, urological symptoms, nausea, fatigue and low backache. 1 We subsequently went on to investigate the prevalence of IBS in gynaecology 2,3 and urology clinics 4 where we found an excess of the condition with these individuals having a poor outcome compared to those with proven gynaecological or urological pathology. We have even found that IBS in elderly care clinics is seldom detected with the potential for patients to undergo excessive investigation. 5 We have also shown that not only does the presence of these non-colonic symptoms help to substantiate the diagnosis of IBS, 6 but also that patients sometimes report that a particular non-colonic symptom may be more intrusive than their bowel problem. 7 This latter observation led us to speculate that if a patient in primary care had a particularly troublesome non-colonic symptom they may be referred to the "wrong" specialty, where they could undergo inappropriate investigation or even surgery. However, there is little information on the prevalence of non-colonic symptoms in primary care and it could be argued that these features may tend to be confined to secondary care patients where the IBS is more bothersome and severe. 
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The development of the EHAS is a crucial element in further defining perceptive populations (as distinct from "normal" perception or hyposensitivity) who report higher symptom burden and are more likely to have diagnosed affective disorders. 6, 8, 9 The EHAS tool also has potential to quantify coping behaviours, which can affect management outcome. Beyond the full EHAS score, further development and validation of distinct subscales for hypervigilance, hypersensitivity, catastrophising, coping behaviours and disease-associated anxiety is critical. These subscales have the potential to define characteristics of the poor responder to therapy, and more importantly, allow targeting of management. For instance, patients with functional bowel disorders with superimposed affective disorders or somatization often do not tolerate, or do not respond well to, antidepressant therapy; 10 these patients could be offered treatments specific for their identified mechanism. Future investigations must address how EHAS values should be interpreted-distributions of data from normal and abnormal patient populations are needed to further define thresholds for each subscale. The precise role of each subscale element in symptomatic patients not responding to typical therapies can be evaluated, which can lead to better understanding of symptom generation and persistence. However, it is the outcome of differential therapies targeted towards abnormal EHAS scores that will solidify the role of this tool in clinical oesophagology.
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